Rapamycin impairs HPD-induced beneficial effects on glucose homeostasis.


BACKGROUND AND PURPOSE Rapamycin, which is used clinically to treat graft rejection, has also been proposed to have an effect on metabolic syndrome; however, very little information is available on its effects in lean animals/humans. The purpose of this study was to characterize further the effects of the continuous use of rapamycin on glucose homeostasis… (More)
DOI: 10.1111/bph.13168

7 Figures and Tables


  • Presentations referencing similar topics